Tenon Medical公司在一笔私人交易中筹集了430万美元,用于为增长和发展提供资金,2026年到期应付款。 Tenon Medical raised $4.3 million in a private deal to fund growth and development, with notes due in 2026.

Tenon Medical， Inc.完成了一项私募，从高级可转换本票中筹集了430万美元的总收益，并享有20%的原始发行折扣，到期日期为2026年9月11日。 Tenon Medical, Inc. closed a private placement raising $4.3 million in gross proceeds from senior convertible promissory notes with a 20% original issue discount, maturing September 11, 2026. 这些票据按前三天量加权平均价格的80%发放后六个月可兑换成共同股票。 The notes are convertible into common stock six months after issuance at 80% of the prior three-day volume-weighted average price. 收益将资助商业扩张、产品开发、临床研究和公司的一般需要。 Proceeds will fund commercial expansion, product development, clinical studies, and general corporate needs. 该公司开发了包括Catamaran SI 联合融合系统在内的肉宫紊乱医疗设备,注意到前瞻性陈述有风险。 The company, which develops medical devices for sacro-pelvic disorders including the Catamaran SI Joint Fusion System, noted forward-looking statements are subject to risks. 纸条和基本股份未经登记,不能无一例外地出售。 The notes and underlying shares are unregistered and may not be sold without exemption.